Cullinan Therapeutics, Inc. (CGEM)
14.70
-0.28
(-1.90%)
USD |
NASDAQ |
May 07, 16:00
14.70
0.00 (0.00%)
After-Hours: 20:00
Cullinan Therapeutics Total Assets (Quarterly) : 449.14M for Dec. 31, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Gilead Sciences, Inc. | 59.02B |
| Elevance Health, Inc. | 125.83B |
| Nkarta, Inc. | 417.29M |
| Janux Therapeutics, Inc. | 1.008B |
| Zenas BioPharma, Inc. | 383.64M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 40.41M |
| Shareholders Equity (Quarterly) | 408.73M |
| Debt to Equity Ratio | 0.0066 |
| Current Ratio | 10.25 |
| Net Debt Paydown Yield | -0.01% |